NCT02344485 is a NA clinical trial of OMM treatment in Parkinson's Disease, sponsored by New York Institute of Technology.

Who is sponsoring NCT02344485?

NCT02344485 is sponsored by New York Institute of Technology.

What drugs are being tested in NCT02344485?

Interventions in NCT02344485: OMM treatment.

What condition does NCT02344485 study?

NCT02344485 studies Parkinson's Disease, Constipation.

Is NCT02344485 still recruiting?

NCT02344485 is currently status unknown. Last updated 13 November 2023.

Last reviewed 2023-11-13 · How we verify

NCT02344485

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Osteopathic Manipulative Medicine on Constipation in Parkinson's Disease

Status unknown NA Last updated 13 November 2023

What this trial tests

NA trial testing OMM treatment in Parkinson's Disease in 20 participants. Status unknown.

Timeline

1 January 2015

Primary endpoint
31 December 2024

31 December 2024

Quick facts

Lead sponsor	New York Institute of Technology
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	1 January 2015
Primary completion	31 December 2024
Estimated completion	31 December 2024
Sites	1 location across United States

Drugs / interventions tested

OMM treatment

Conditions studied

Parkinson's Disease — all drugs for Parkinson's Disease →
Constipation — all drugs for Constipation →

Sponsor

New York Institute of Technology

Who can join

40 and older, any sex, with Parkinson's Disease or Constipation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Gut Microbiome Changes with Osteopathic Treatment of Constipation in Parkinson's Disease: A Pilot Study.
Mancini JD, Yao S, Martinez LR, Shakil H, et al · · 2021 · cited 5× · PMID 33899052

Verify or expand the search:

Other recruiting trials for Parkinson's Disease

Currently open trials in the same condition.

NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
NCT07330258 — A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite · recruiting
NCT07384429 — Effects of Lemborexant on Motor-sleep Comorbidity in Parkinson's Disease · Phase 4 · recruiting
NCT07384442 — Effects of Targeted Temporal Interference Stimulation of Cerebellar Nuclei on Tremor and Gait Disturbance in Parkinson's · NA · recruiting
NCT06562569 — Non-invasive VNS for PD Gait · NA · recruiting

Other New York Institute of Technology trials

Trials by the same sponsor.

NCT07341204 — How Virtual Reality Can Help Neurodivergent Children Improve Their Attention · NA · not yet recruiting
NCT07362329 — Use of Exercise Snacks to Improve Upper Body Fitness · NA · active not recruiting
NCT07218614 — Can Mobilizations Applied to the Thoracic Spine Improve Oxygen Saturation Levels and Thoracic Kyphosis in E-Cigarette Sm · NA · not yet recruiting
NCT06671600 — Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects · NA · not yet recruiting
NCT06546462 — Can a Specific OMT Protocol Influence Patient Pain and Associated Analgesia Use for Primary Headache Disorders? · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02344485 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by New York Institute of Technology
Last refreshed: 13 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02344485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing